Article info

PDF
Response to: ‘Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia’ by Morton and Thompson

Authors

  • Tim Badgery-Parker Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, AustraliaCapital Markets CRC, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sallie-Anne Pearson Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ian A Scott School of Clinical Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Adam G Elshaug Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Tim Badgery-Parker, Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, The University of Sydney, Sydney, NSW 2006, Australia; tim.badgeryparker{at}sydney.edu.au
View Full Text

Citation

Badgery-Parker T, Pearson S, Scott IA, et al
Response to: ‘Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia’ by Morton and Thompson

Publication history

  • Received December 12, 2018
  • Accepted December 13, 2018
  • First published January 3, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.